RetinalGenix Technologies

RetinalGenix Technologies FCF/Debt

The Free Cash Flow to Debt Ratio of RetinalGenix Technologies (RTGN) as of Oct 30, 2026 is -407.33 %.

FCF/Debt

-407.33 %

Last updated:

Free Cash Flow to Debt Ratio of RetinalGenix Technologies is 2022 -407.33 % . Free Cash Flow to Debt Ratio of RetinalGenix Technologies was 2021 - . It decreases by % lower compared to the previous year.

The RetinalGenix Technologies FCF/Debt history

The RetinalGenix Technologies FCF/Debt history
YEARFCF/DebtYoY
-407.33 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RetinalGenix Technologies Stock analysis

What does RetinalGenix Technologies do? RetinalGenix Technologies Inc, based in Petaluma, California, is a medical device company focused on ocular health. The company develops innovative solutions for screening, monitoring, diagnosing, and treating sight-threatening disorders, particularly diabetic retinopathy and maculopathy. Its key products include the Retinal Imaging Screening Device, a portable system offering a 200-degree field of view without pupil dilation, and RetinalCam, a home monitoring device with 24/7 physician access for real-time communication. Both devices aim to address vision loss and blindness through advanced imaging technology. RetinalGenix Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RetinalGenix Technologies stock

Free Cash Flow to Debt Ratio of RetinalGenix Technologies is -407.33 % in 2022.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio RetinalGenix Technologies since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's RetinalGenix Technologies with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — RetinalGenix Technologies

All Key Metrics — RetinalGenix Technologies